Analyst Ratings For NYSE:GKOS – Glaukos (NYSE:GKOS)
Today, BMO Capital Markets reiterated its Outperform ➝ Buy rating on NYSE:GKOS – Glaukos (NYSE:GKOS) with a price target of $40.00 ➝ $42.00.
Some recent analyst ratings include
- 6/1/2018-BMO Capital Markets Reiterated Rating of Outperform ➝ Buy.
- 4/13/2018-Stifel Nicolaus was Downgraded by analysts at Stifel Nicolaus from a “Buy ➝ Hold” rating to a “” rating. They now have a $39.00 ➝ $32.00 price target on the stock.
- 3/23/2018-William Blair Reiterated Rating of Outperform.
- 3/1/2018-Stephens Reiterated Rating of Buy.
- 9/15/2017-Piper Jaffray Companies Reiterated Rating of Positive ➝ Buy.
- On 3/6/2018 Orbimed Advisors Llc, Director, sold 836,500 with an average share price of $32.02 per share and the total transaction amounting to $26,784,730.00.
- On 3/2/2018 Jonathan Silverstein, Director, sold 464,583 with an average share price of $32.29 per share and the total transaction amounting to $15,001,385.07.
- On 11/22/2017 Joseph E Gilliam, CFO, bought 2,100 with an average share price of $23.84 per share and the total transaction amounting to $50,064.00.
- On 9/7/2017 Thomas William Burns, CEO, sold 73,788 with an average share price of $41.36 per share and the total transaction amounting to $3,051,871.68.
- On 9/5/2017 Orbimed Advisors Llc, Director, sold 580,200 with an average share price of $38.73 per share and the total transaction amounting to $22,471,146.00.
- On 9/5/2017 Thomas William Burns, CEO, sold 1,212 with an average share price of $41.25 per share and the total transaction amounting to $49,995.00.
- On 8/17/2017 Orbimed Advisors Llc, Director, sold 325,000 with an average share price of $37.93 per share and the total transaction amounting to $12,327,250.00.
Recent Trading Activity for NYSE:GKOS – Glaukos (NYSE:GKOS)
Shares of NYSE:GKOS – Glaukos closed the previous trading session at 38.40 up +0.64 1.69% with shares trading hands.